Allotrap-07

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameAllotrap-07
Drug Alias NameB7.75-84
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionCytotoxic T lymphocytes inhibitors
TargetsUpdating
Therapy Area/IndicationsRejection of organ transplantation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFrance
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGenzyme Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInsermGenzyme Corp
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantation

Other Information

ATC CodeN/A
Related LinksN/A